Agile Therapeutics, Inc

(NASDAQ:AGRX)

Latest On Agile Therapeutics, Inc (AGRX):

Date/Time Type Description Signal Details
2023-05-23 08:37 ESTNewsAgile Therapeutics prices $7.5M offeringN/A
2023-05-12 20:16 ESTNewsAgile Therapeutics, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-12 20:16 ESTNewsAgile Therapeutics, Inc. (AGRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 16:22 ESTNewsAgile Therapeutics GAAP EPS of -$5.91 beats by $1.59, revenue of $3.81M beats by $0.41MN/A
2023-05-11 01:45 ESTNewsAgile Therapeutics Q1 2023 Earnings PreviewN/A
2023-04-10 18:48 ESTNewsAgile approves 1-for-50 reverse stock splitN/A
2023-03-24 22:33 ESTNewsAgile Therapeutics, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-24 22:33 ESTNewsAgile Therapeutics, Inc (AGRX) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 23:18 ESTNewsAgile Therapeutics GAAP EPS of -$0.10 beats by $0.12, revenue of $4M beats by $0.87MN/A
2023-02-27 11:17 ESTNewsNasdaq grants Agile Therapeutics 180-day extension to regain complianceN/A
2023-02-01 13:31 ESTNewsTwirla, FDA agree on details for Twirla birth control patch post-marketing requirementsN/A
2023-01-09 13:07 ESTNewsAgile stock rises as 2023 revenue seen up to $30MN/A
2022-11-09 01:56 ESTNewsAgile Therapeutics stock falls ~17% following mixed Q3 resultsN/A
2022-11-08 07:39 ESTNewsAgile Therapeutics GAAP EPS of -$0.53 misses by $0.23, revenue of $3M beats by $0.67MN/A
2022-11-08 07:39 ESTNewsAgile Therapeutics, Inc. (AGRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-06 22:49 ESTNewsAgile Therapeutics Q3 2022 Earnings PreviewN/A
2022-10-10 09:02 ESTNewsAgile appoints chief commercial officer from within ranks amid leadership revampN/A
2022-09-14 18:07 ESTNewsAgile Therapeutics (AGRX) presents at H.C. Wainwright 24th Annual Global Investment Conference - SlideshowN/A
2022-08-11 22:36 ESTNewsAgile Therapeutics GAAP EPS of -$2.71 beats by $0.99, revenue of $2.1M beats by $0.12MN/A
2022-08-11 22:35 ESTNewsAgile Therapeutics, Inc. (AGRX) CEO Al Altomari on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 05:48 ESTNewsAgile Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-13 11:57 ESTNewsCircling Back On Agile TherapeuticsN/A
2022-07-12 22:36 ESTNewsAgile Therapeutics updates Q2 guidanceN/A
2022-07-11 15:01 ESTNewsAgile gains as H.C. Wainwright sees 630% upside potentialN/A
2022-07-01 18:36 ESTNewsAgile Therapeutics prices $24M upsized stock offeringN/A
2022-05-13 06:49 ESTNewsAgile Therapeutics GAAP EPS of -$3.78 beats by $2.22, revenue of $1.76M beats by $0.54MN/A
2022-05-13 06:49 ESTNewsAgile Therapeutics, Inc. (AGRX) CEO Al Altomari on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 18:31 ESTNewsAgile Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-27 18:19 ESTNewsAgile Therapeutics to raise $13M in stock offering, provides certain Q1 estimates and reverse stock split effective Apr.27N/A
2022-04-26 08:24 ESTNewsAgile Therapeutics stock gains on 1-for-40 reverse stock splitN/A
2022-04-04 13:37 ESTNewsAgile Therapeutics: Twirla's Lackluster Launch Forces Me To Change My StrategyN/A
2022-04-01 02:21 ESTNewsAgile Therapeutics stock slumps 10% following Q4 resultsN/A
2022-03-31 06:34 ESTNewsAgile Therapeutics GAAP EPS of -$0.20, revenue of $1.51MN/A
2022-03-31 06:34 ESTNewsAgile Therapeutics, Inc.'s (AGRX) CEO Al Altomari On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 21:35 ESTNewsAgile Therapeutics Q4 Earnings PreviewN/A
2022-03-14 23:22 ESTNewsAgile Therapeutics stock slips on $4.85M equity offeringN/A
2021-11-14 05:24 ESTNewsAgile Therapeutics: Worst Is OverN/A
2021-11-04 03:28 ESTNewsAgile Therapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-03 07:29 ESTNewsAgile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 11:39 ESTNewsAgile Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-20 02:11 ESTNewsAgile Therapeutics: Bullish On Capitulation And Max PainN/A
2021-10-18 08:10 ESTNewsAgile Therapeutics gains as leading holder increases stakeN/A
2021-10-08 22:42 ESTNewsAgile Therapeutics prices $22.7M public offering; shares down 20%N/A
2021-10-08 22:41 ESTNewsAgile Therapeutics adds Josephine Torrente to its board of directorsN/A
2021-10-08 02:55 ESTNewsAgile Therapeutics slumps 16% after launching stock offeringN/A
2021-08-20 19:23 ESTNewsAgile Therapeutics partners with telehealth service, Pandia HealthN/A
2021-07-31 04:27 ESTNewsAgile Therapeutics: Another Quarter Of Progress And Another Opportunity To BuyN/A
2021-07-27 05:23 ESTNewsAgile Therapeutics EPS beats by $0.01, misses on revenueN/A
2021-07-27 05:23 ESTNewsAgile Therapeutics Q2 2021 net loss widens as marketing expenses growN/A
2021-07-27 05:23 ESTNewsAgile Therapeutics, Inc.'s (AGRX) CEO Al Altomari on Q2 2021 Results - Earnings Call TranscriptN/A

About Agile Therapeutics, Inc (AGRX):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

AGRX Quotes by TradingView

See Advanced Chart

General

  • Name Agile Therapeutics, Inc
  • Symbol AGRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 28
  • Fiscal Year EndDecember
  • IPO Date2014-05-23
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.agiletherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 234.04
  • Price/Book (Most Recent Quarter) 3.68
  • Enterprise Value Revenue 191.51
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.60
  • Next Year EPS Estimate -$0.13
  • Next Quarter EPS Estimate -$0.19
  • Operating Margin -6549%
  • Return on Assets -50%
  • Return on Equity -109%
  • Revenue 749000
  • Earnings Per Share -$0.42
  • Revenue Per Share $0.01
  • Gross Profit 467000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 179.64 million
  • EBITDA -14902000
  • Analyst Target Price $8.25
  • Book Value Per Share $0.56
View More

Share Statistics

  • Shares Outstanding 87.63 million
  • Shares Float 70.92 million
  • % Held by Insiders 98%
  • % Held by Institutions 49.81%
  • Shares Short 2.68 million
  • Shares Short Prior Month 2.35 million
  • Short Ratio 1.7
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.14
  • 52 Week High $3.89
  • 52 Week Low $1.45
  • 50 Day Moving Average 2.81
  • 200 Day Moving Average 2.95
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Agile Therapeutics, Inc (AGRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Agile Therapeutics, Inc (AGRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$749000-$0.20-$0.2210.71%
2020-09-302020-11-12$N/A-$0.18-$0.18-1.12%
2020-06-302020-08-11$N/A-$0.12-$0.1414.29%
2020-03-312020-05-05$N/A-$0.10-$0.09-15.34%
2019-12-312020-02-20$N/A-$0.10-$0.08-33.33%
2019-09-302019-10-28$N/A-$0.08-$0.082.08%
2019-06-302019-08-01$N/A-$0.08-$0.1127.27%
2019-03-312019-05-02$N/A-$0.13-$0.10-36.84%
2018-12-312019-03-12$N/A-$0.10-$0.1634.19%
2018-09-302018-11-01$N/A-$0.11-$0.1528.25%
2018-06-302018-08-03$N/A-$0.14-$0.1712.85%
2018-03-312018-05-07$N/A-$0.21-$0.20-6.06%
2017-12-312018-03-12$N/A-$0.18-$0.2321.26%
2017-09-302017-11-06$N/A-$0.22-$0.2512.59%
2017-06-302017-07-28$N/A-$0.26-$0.285.8%
2017-03-312017-05-08$N/A-$0.26-$0.3013.33%
2016-12-312017-03-08$N/A-$0.18-$0.3040.79%
2016-09-302016-11-07$N/A-$0.27-$0.3420.59%
2016-06-302016-08-08$N/A-$0.29-$0.290.58%
2016-03-312016-05-09$N/A-$0.27-$0.3625.68%
2015-12-312016-03-09$N/A-$0.17-$0.4562.22%
2015-09-302015-11-09$N/A-$0.42-$0.420%
2015-06-302015-08-13$N/A-$0.38-$0.37-2.7%
2015-03-312015-05-12$N/A-$0.40-$0.34-17.65%
2014-12-312015-03-26$N/A-$0.37-$0.4313.95%
2014-09-302014-11-13$N/A-$0.34-$0.5032%
2014-06-302014-08-14$N/A-$0.28-$0.3622.22%
2014-03-312014-05-28$N/A$0.00

Agile Therapeutics, Inc (AGRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Agile Therapeutics, Inc (AGRX) Chart:

Agile Therapeutics, Inc (AGRX) News:

Below you will find a list of latest news for Agile Therapeutics, Inc (AGRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Agile Therapeutics, Inc (AGRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest AGRX Trades:

Date Shares Price
Jun 13, 2022 12:49 PM EST38$1.27
Jun 13, 2022 4:53 PM EST2$1.14
Jun 13, 2022 7:50 PM EST11$1.14
Jun 13, 2022 7:57 PM EST100$1.14

Agile Therapeutics, Inc (AGRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020007854/0001558370-20-007854-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000089924319006367/0000899243-19-006367-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000089924319026360/0000899243-19-026360-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000089924319026431/0000899243-19-026431-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000089924320005836/0000899243-20-005836-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000089924320008589/0000899243-20-008589-index.htm
2018-09-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000092963818000765/0000929638-18-000765-index.htm
2018-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000101297518000932/0001012975-18-000932-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000103738919000003/0001037389-19-000003-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000103738920000135/0001037389-20-000135-index.htm
2018-11-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1261249/000104746918007013/0001047469-18-007013-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1261249/000104746919000195/0001047469-19-000195-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1261249/000104746919001136/0001047469-19-001136-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1261249/000104746919002585/0001047469-19-002585-index.htm
2019-08-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1261249/000104746919004492/0001047469-19-004492-index.htm
2019-08-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1261249/000104746919004520/0001047469-19-004520-index.htm
2019-11-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1261249/000104746919006192/0001047469-19-006192-index.htm
2020-02-2010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1261249/000104746920000966/0001047469-20-000966-index.htm
2020-02-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1261249/000104746920000969/0001047469-20-000969-index.htm
2020-02-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1261249/000104746920000994/0001047469-20-000994-index.htm
2018-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465918049347/0001104659-18-049347-index.htm
2018-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000110465918049513/0001104659-18-049513-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465918060771/0001104659-18-060771-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465918060954/0001104659-18-060954-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465918063591/0001104659-18-063591-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465918065441/0001104659-18-065441-index.htm
2018-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000110465918065593/0001104659-18-065593-index.htm
2018-11-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1261249/000110465918065769/0001104659-18-065769-index.htm
2018-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465918072839/0001104659-18-072839-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919000502/0001104659-19-000502-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919000994/0001104659-19-000994-index.htm
2019-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919001481/0001104659-19-001481-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919002849/0001104659-19-002849-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919003713/0001104659-19-003713-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919003714/0001104659-19-003714-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919003715/0001104659-19-003715-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919003716/0001104659-19-003716-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919003717/0001104659-19-003717-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919004817/0001104659-19-004817-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919004818/0001104659-19-004818-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919004819/0001104659-19-004819-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919004820/0001104659-19-004820-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919004821/0001104659-19-004821-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919007141/0001104659-19-007141-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919012545/0001104659-19-012545-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919014261/0001104659-19-014261-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919015610/0001104659-19-015610-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919016026/0001104659-19-016026-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919017469/0001104659-19-017469-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919018999/0001104659-19-018999-index.htm
2019-04-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919019002/0001104659-19-019002-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919026495/0001104659-19-026495-index.htm
2019-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000110465919026838/0001104659-19-026838-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919027152/0001104659-19-027152-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919030128/0001104659-19-030128-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919031110/0001104659-19-031110-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034302/0001104659-19-034302-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034553/0001104659-19-034553-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034554/0001104659-19-034554-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034556/0001104659-19-034556-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034557/0001104659-19-034557-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034558/0001104659-19-034558-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034559/0001104659-19-034559-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919034790/0001104659-19-034790-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919037213/0001104659-19-037213-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919038107/0001104659-19-038107-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919038370/0001104659-19-038370-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919039579/0001104659-19-039579-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919039580/0001104659-19-039580-index.htm
2019-07-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919039872/0001104659-19-039872-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919041329/0001104659-19-041329-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919043195/0001104659-19-043195-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000110465919043196/0001104659-19-043196-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919043328/0001104659-19-043328-index.htm
2019-08-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919043736/0001104659-19-043736-index.htm
2019-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919043744/0001104659-19-043744-index.htm
2019-08-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919044316/0001104659-19-044316-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465919044317/0001104659-19-044317-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919044909/0001104659-19-044909-index.htm
2019-10-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000110465919056670/0001104659-19-056670-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919056684/0001104659-19-056684-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919058371/0001104659-19-058371-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919061736/0001104659-19-061736-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465919064282/0001104659-19-064282-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465920002279/0001104659-20-002279-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920006857/0001104659-20-006857-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920006858/0001104659-20-006858-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920006859/0001104659-20-006859-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920006860/0001104659-20-006860-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465920017854/0001104659-20-017854-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465920022281/0001104659-20-022281-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465920023400/0001104659-20-023400-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465920023929/0001104659-20-023929-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000110465920025410/0001104659-20-025410-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920026463/0001104659-20-026463-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920029907/0001104659-20-029907-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920034104/0001104659-20-034104-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072478/0001104659-20-072478-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072480/0001104659-20-072480-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072483/0001104659-20-072483-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072484/0001104659-20-072484-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072486/0001104659-20-072486-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072487/0001104659-20-072487-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072488/0001104659-20-072488-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920072489/0001104659-20-072489-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920076109/0001104659-20-076109-index.htm
2020-08-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920096161/0001104659-20-096161-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920096165/0001104659-20-096165-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920097236/0001104659-20-097236-index.htm
2020-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920098733/0001104659-20-098733-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000110465920109302/0001104659-20-109302-index.htm
2020-10-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1261249/000110465920111069/0001104659-20-111069-index.htm
2020-10-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1261249/000110465920111722/0001104659-20-111722-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000119312519040984/0001193125-19-040984-index.htm
2019-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000119312519064818/0001193125-19-064818-index.htm
2019-10-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000119312519278992/0001193125-19-278992-index.htm
2019-11-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000119312519294839/0001193125-19-294839-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000119312520038078/0001193125-20-038078-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1261249/000121390020003666/0001213900-20-003666-index.htm
2019-03-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1261249/000126124919000001/0001261249-19-000001-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020004156/0001558370-20-004156-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1261249/000155837020004292/0001558370-20-004292-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020005100/0001558370-20-005100-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020005192/0001558370-20-005192-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000155837020005210/0001558370-20-005210-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020007389/0001558370-20-007389-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020007854/0001558370-20-007854-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020010323/0001558370-20-010323-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1261249/000155837020010330/0001558370-20-010330-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020010710/0001558370-20-010710-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1261249/000155837020011221/0001558370-20-011221-index.htm
2018-11-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1261249/999999999518002891/9999999995-18-002891-index.htm
2020-10-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1261249/999999999520002846/9999999995-20-002846-index.htm

Agile Therapeutics, Inc (AGRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agile Therapeutics, Inc (AGRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 98%
Institutional Ownership: 4981%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-28Dennis ReillyChief Financial OfficerBuy9,000.002.8525,650.00106,306.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920109302/0001104659-20-109302-index.htm
2019-08-06PERCEPTIVE ADVISORS LLC10% Share HolderBuy2,300,000.000.952,185,000.0010,726,750.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319026360/0000899243-19-026360-index.htm
2019-11-15PERCEPTIVE ADVISORS LLC10% Share HolderBuy2,000,000.001.603,200,000.0011,586,125.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm
2019-11-15PERCEPTIVE ADVISORS LLC10% Share HolderBuy333,800.001.74580,812.0011,919,925.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm
2020-01-22Robert G ConwaySr. VP Manufacturing & SupplyBuy6,272.0012,547.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920006857/0001104659-20-006857-index.htm
2020-02-25PERCEPTIVE ADVISORS LLC10% Share HolderBuy3,000,000.003.009,000,000.0014,919,925.00https://www.sec.gov/Archives/edgar/data/1261249/000089924320005836/0000899243-20-005836-index.htm
2020-03-13PERCEPTIVE ADVISORS LLC10% Share HolderBuy1,000,000.001.751,750,000.0015,919,925.00https://www.sec.gov/Archives/edgar/data/1261249/000089924320008589/0000899243-20-008589-index.htm
2019-01-24ALFRED ALTOMARIChief Executive OfficerBuy35,314.00213,568.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003713/0001104659-19-003713-index.htm
2019-03-25ALFRED ALTOMARIChief Executive OfficerBuy25,000.001.5438,500.00238,568.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919017469/0001104659-19-017469-index.htm
2020-03-04Dennis ReillyChief Financial OfficerBuy25,000.002.3558,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920029907/0001104659-20-029907-index.htm
2019-06-10ALFRED ALTOMARIChief Executive OfficerBuy20,000.001.2725,400.00258,568.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919034790/0001104659-19-034790-index.htm
2020-06-09Sandra CarsonDirectorBuy26,786.0026,786.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920072484/0001104659-20-072484-index.htm
2020-06-09SHARON BARBARIDirectorBuy26,786.0026,786.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920072483/0001104659-20-072483-index.htm
2019-01-24Geoffrey GilmoreGeneral CounselBuy16,480.0028,212.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003714/0001104659-19-003714-index.htm
2020-01-22ALFRED ALTOMARIChief Executive OfficerBuy26,502.00285,070.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920006858/0001104659-20-006858-index.htm
2020-02-27ALFRED ALTOMARIChief Executive OfficerBuy16,541.000.7111,744.11301,611.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920026463/0001104659-20-026463-index.htm
2019-01-24Elizabeth GarnerSr. VP & Chief Medical OfficerBuy18,565.0030,300.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003716/0001104659-19-003716-index.htm
2019-01-24Scott M CoianteChief Financial OfficerBuy16,070.0030,756.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003715/0001104659-19-003715-index.htm
2020-02-27ALFRED ALTOMARIChief Executive OfficerBuy10,000.002.7127,100.00311,611.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920026463/0001104659-20-026463-index.htm
2020-06-09James Patrick TursiDirectorBuy13,393.0031,342.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920072488/0001104659-20-072488-index.htm
2020-06-09John W HubbardDirectorBuy13,393.0031,342.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920072486/0001104659-20-072486-index.htm
2020-06-09Seth H. Z. FischerDirectorBuy13,393.0031,342.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920072489/0001104659-20-072489-index.htm
2018-07-26PERCEPTIVE ADVISORS LLCInsiderSell298,628.000.3089,439.093,231,372.00https://www.sec.gov/Archives/edgar/data/1261249/000101297518000932/0001012975-18-000932-index.htm
2020-06-22ALFRED ALTOMARIChief Executive OfficerBuy50,000.001.7688,000.00361,611.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920076109/0001104659-20-076109-index.htm
2019-03-29Abhijeet J LeleDirectorBuy20,000.001.5430,800.0037,949.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919018999/0001104659-19-018999-index.htm
2020-06-09Ajit ShettyDirectorBuy13,393.0038,342.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920072487/0001104659-20-072487-index.htm
2020-08-20ALFRED ALTOMARIChief Executive OfficerBuy94,599.001.76166,494.24456,210.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920097236/0001104659-20-097236-index.htm
2019-01-25Geoffrey GilmoreGeneral CounselBuy17,500.0045,712.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003714/0001104659-19-003714-index.htm
2019-01-25Elizabeth GarnerSr. VP & Chief Medical OfficerBuy17,500.0047,800.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003716/0001104659-19-003716-index.htm
2019-01-25Scott M CoianteChief Financial OfficerBuy17,500.0048,256.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003715/0001104659-19-003715-index.htm
2020-01-22Geoffrey GilmoreGeneral CounselBuy10,071.0055,783.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920006860/0001104659-20-006860-index.htm
2020-03-04Dennis ReillyChief Financial OfficerBuy50,000.002.32116,000.0059,806.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920029907/0001104659-20-029907-index.htm
2019-10-29PERCEPTIVE ADVISORS LLC10% Share HolderSell760,291.000.44334,528.046,151,110.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319026431/0000899243-19-026431-index.htm
2019-11-14PERCEPTIVE ADVISORS LLC10% Share HolderBuy435,015.001.69735,175.356,586,125.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm
2019-10-28PERCEPTIVE ADVISORS LLC10% Share HolderSell3,815,349.000.511,945,827.996,911,401.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319026360/0000899243-19-026360-index.htm
2020-03-13Geoffrey GilmoreGeneral CounselBuy25,500.001.5639,780.0081,283.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920034104/0001104659-20-034104-index.htm
2019-01-24Robert G ConwaySVP Ent Planning & Info MgtBuy8,625.008,625.00https://www.sec.gov/Archives/edgar/data/1261249/000110465919003717/0001104659-19-003717-index.htm
2019-11-15PERCEPTIVE ADVISORS LLC10% Share HolderBuy3,000,000.001.725,160,000.009,586,125.00https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm
2020-08-26Dennis ReillyChief Financial OfficerBuy37,500.001.0137,875.0097,306.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920098733/0001104659-20-098733-index.htm
2020-01-22Dennis ReillyChief Financial OfficerBuy9,806.009,806.00https://www.sec.gov/Archives/edgar/data/1261249/000110465920006859/0001104659-20-006859-index.htm